Hangzhou Tigermed Consulting Co., Ltd.
Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HNGZY · as of Jun 10, 2026
Key Statistics
Explore Hangzhou Tigermed Consulting Co., Ltd. Data
hngzy stock data · financialsAbout Hangzhou Tigermed Consulting Co., Ltd.
Hangzhou Tigermed Consulting Co., Ltd. operates as a prominent contract research organization (CRO), delivering an extensive array of services across the People's Republic of China and globally. Its o…
what is hangzhou tigermed consulting co., ltd. · hngzy stock overview · hangzhou tigermed consulting co., ltd. company profile · who is hangzhou tigermed consulting co., ltd. ceo · hngzy OTC · hangzhou tigermed consulting co., ltd. headquarters · hangzhou tigermed consulting co., ltd. business segments
About Stock Overview & Key Data
Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on OTC since Jul 11, 2022. As of the latest trading session, HNGZY stock price is $4.00, with a market capitalization of $6.2B. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) stock price is $4.00. The stock is traded on OTC under the ticker symbol HNGZY. The 52-week range is $4.00 – $4.28.